The Medical Advisory Board
Rubicon has assembled a multi-disciplined team of physicians that are among the world ’s
leaders in neuro-interventional radiology,interventional cardiology,and interventional radi-
ology.This Medical Advisory Board (MAB)has been a crucial part of Rubicon ’s success in
developing the Guardian System and the vascular filter platform.Moreover,the MAB serves
a critical role in the discovery of new technologies and techniques.
The MAB works closely with Research &Development in the evolution of Rubicon ’s tech-
nologies.They work continuously with Rubicon ’s R&D engineers in all aspects of project
management,research &testing,device design,protocols,and design approvals.In short,
devices at Rubicon mature through a collaborative process involving both physician and
engineer.
Randall T.Higashida,M.D.
Medical Director
Dr.Higashida currently is Clinical Professor of Radiology and Neurological Surgery at the
University of California,San Francisco Medical Center.He is Chief of the Division of
Interventional Neurovascular Radiology.The UCSF group is considered one of the premier
groups in the world that specializes in this field.They perform more than 1200 interven-
tional and diagnostic procedures per year in Stroke and Cerebrovascular Disease.
Dr.Higashida ’s resume includes the following:The current President Elect of the American
Society of Interventional and Therapeutic Neuroradiology;Current Chairman of the
American Heart Association Cerebrovascular and Stroke Council;Executive Council of the
American Society of Neuroradiology;current Executive Council of the Joint Section of
Cerebrovascular Neurosurgery;Food and Drug Administration (FDA)Committee for the
Cardiovascular and Interventional Radiology Society for Medical Devices;National
Institutes of Health (NIH)Patient Safety and Monitoring Board for the Carotid Artery
Stenting Trial;8 editorial boards 4 scientific journals;Executive Advisory Board for Abbott
Laboratories Thrombolytics Venture for Stroke and Cerebrovascular Diseases;more than 185
scientific peer reviewed articles on interventional neuroradiology devices,techniques,and
procedures;over 85 scientific book chapters on interventional neuroradiology techniques
and procedures;more than 350 invited lectures at international,national,and regional scien-
tific meetings;greater than 290 scientific and professional meeting submitted presentations;
21 current research projects and clinical trials;and 26 funded scientific grants and awards.
Dr.Higashida is listed in "The Best Doctor ’s in America","San Francisco Bay Area Best
Doctors",and "Who ’s Who in America:Outstanding Physicians".He is the former Medical
Director of Interventional Therapeutics Corporation from 1986 – 1993,,and he is a consultant
to the FDA Neurological Devices Panel.
Barry T.Katzen,M.D.,FACR,FACC
Barry T.Katzen,M.D.,is the founder and Medical Director of Miami Cardiac &ascular
Institute,an affiliate of Baptist Health Systems of South Florida.He is Professor of Clinical
Radiology at the University of Miami School of Medicine.
Dr.Katzen was born in Miami and went to the University of Miami School of Medicine.
After completing a medical internship,he proceeded to a radiology residency at the New
York Hospital-Cornell Medical Center.He was awarded a Fellowship in Cardiovascular
Radiology at St.incent ’s Hospital and Medical Center in New York,where he ultimately
became Chief of Cardiovascular and Interventional Radiology. |
